Main » Press Releases & News » Vibrant raises $7.5M for innovative drug-free constipation treatment

Vibrant raises $7.5M for innovative drug-free constipation treatment

Published: March 26, 2021

Vibrant, a medical technology company that’s developed a disposable vibrating pill to treat chronic constipation, today announced its Series E for $7.5 million. The company is based in Tel Aviv and is lead by Lior Ben-Tsur, a startup veteran. Since its founding in 2007, the company has raised a total of $25 million. This round is being led by Unorthodox Ventures, with participation by Sequoia.

Posted on:

https://techcrunch.com/2021/03/26/vibrant-raises-7-5m-for-a-drug-free-mechanical-pill-to-treat-constipation/

Related Press Releases & News

Hope for chronic constipation sufferers thanks to vibrating pill that can ‘double the number of weekly bowel movements’

The gadget, called Vibrant and about the size of a fish-oil supplement, sends out pulses that, the designers claim, stimulate natural movements in the gut

A vibrating pill for constipation heads to the FDA after completing phase 3 study

A small, vibrating pill designed to help people with chronic constipation cleared a clinical study and is headed to the FDA for final review. Vibrant

Vibrant’s Novel Drug-Free Treatment Demonstrates Positive Efficacy and Safety Results in Adults with Chronic Idiopathic Constipation in Pivotal Phase 3 Study

The Phase 3 data met all primary endpoints for complete spontaneous bowel movements (CSBMs) per week and showed significant improvement in secondary outcomes versus placebo

Let's be friends -

1. Gut inference: A computational modelling approach: July 22, 2021, Appears in: Biological Psychology
2. Long range synchronization within the enteric nervous system underlies propulsion along the large intestine in mice: August 10, 2021, Appears in: Communications Biology, Nature.com
3. SLACK Incorporated, “Current Insights About Constipation: October 2018
4. Phase III patients’ post research self-reported outcomes
5. Disruption of Circadian Rhythms and Gut Motility: Journal of Clinical Gastroenterology. May/June 2020 – Volume 54 – Issue 5 – p 405-414

This site is published by Vibrant Gastro, Inc.. which is solely responsible for its content.
This site is intended for visitors from the United States. The trademarks used herein are trademarks of their respective owners.

The Vibrant capsule is an investigational device limited to investigational use in the United States. It is currently under FDA review and is not available for sale.